Search ARM

Vascular Research Group (VRG), a peptide-based pharmaceuticals, cellular & gene therapy (CGT) company. VRG generates proprietary proteins/peptides using a directed evolutionary approach and employs them as small protein pharmaceuticals or as targeting molecules in Cellular & Gene Therapeutics. We have assets in the non-traditional CAR-T and in the chemogenetic gene therapy field.

Contact Vascular Research Group
Visit Website